Skip to content
AwardedPRTGoodsFramework agreement€489,665

2024/0963 - VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE]

Published
Published 12 May 2026

Overview

VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE]

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€489,665
Procedure
Selective
Contract type
Framework agreement
Published
12 May 2026
Classification (CPV)
Immune sera and immunoglobulins

Award outcome

Awarded value
€489,665
Award date
2 April 2026
Contract period
— → 28 December 2026
Winner
  • MERCK SHARP & DOHME, LDA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    11 May 2026

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2024/0963 - VACINA CONTRA O VÍRUS DO PAPILOMA HUMANO NONAVALENTE (HPV9) [DOSE] — won by MERCK SHARP & DOHME, LDA — Skim